International Journal of Drug Policy
Volume 21, Issue 5 , Pages 399-406 , September 2010

Composition, purity and perceived quality of street cocaine in France

  • Isabelle Evrard

      Affiliations

    • French Monitoring Centre for Drugs and Drug Addiction, 3 Avenue du Stade de France, 93218 Saint Denis la Plaine, France
    • ,
  • Stéphane Legleye

      Affiliations

    • National Institute for Demographic Studies (Ined), Service des enquêtes et des sondages, 133 Boulevard Davout, 75020 Paris, France
    • National Institute for Medical Research (Inserm) U669 & University Paris XI, Maison de Solenn, 97 Boulevard de Port Royal, 75679 Paris Cedex 14, France
    • French Monitoring Centre for Drugs and Drug Addiction, 3 Avenue du Stade de France, 93218 Saint Denis la Plaine, France
    • Corresponding Author InformationCorresponding author at: INED, Service des enquêtes et des sondages, 133 Boulevard Davout, 75020 Paris, France. Tel.: +33 0 1 56 06 20 98.
    • ,
  • Agnès Cadet-Taïrou

      Affiliations

    • French Monitoring Centre for Drugs and Drug Addiction, 3 Avenue du Stade de France, 93218 Saint Denis la Plaine, France

Received 4 December 2009 ,Revised 10 February 2010 ,Accepted 11 March 2010.

References 

  1. Akaike H. A new look at statistical model identification. IEEE Transactions on automatic control. 1974;19(6):716–723
  2. Ansah TA, Wade LH, Shockley DC. Effects of calcium channel entry blockers on cocaine and amphetamine-induced motor activities and toxicities. Life Sciences. 1993;53(26):1947–1956
  3. Beck, F., Legleye, S., Spilka, S., Briffault, X., Gautier, A., Lamboy, B., et al. (2006). Les niveaux d’usage des drogues en France en 2005. Exploitation des données du Baromètre santé 2005 relatives aux pratiques d’usage de substances psychoactives en population adulte. Tendances (48), p. 6.
  4. Bickel WK, Marsch LA. Toward a behavioral economic understanding of drug dependence: Delay discounting processes. Addiction. 2001;96(1):73–86
  5. Boermans P, Go H, Wessels A, Uges D. Quantification by HPLC–MS/MS of atropine in human serum and clinical presentation of six mild-to-moderate intoxicated atropine-adulterated-cocaine users. Therapeutic Drug Monitoring. 2006;28(3):295–298
  6. Brunt T, Rigter S, Hoek J, Vogels N, van Dijk P, Niesink R. An analysis of cocaine powder in the Netherlands: Content and health hazards due to adulterants. Addiction. 2009;104(5):798–805
  7. Buchanan D, Tooze JA, Shaw S, Kinzly M, Heimer R, Singer M. Demographic, HIV risk behavior, and health status characteristics of “crack” cocaine injectors compared to other injection drug users in three New England cities. Drug and Alcohol Dependence. 2006;81(3):221–229
  8. Cadet-Taïrou A, Gandilhon M, Toufik A, Evrard I. In: The eighth national report from the TREND system. Saint-Denis: OFDT; 2008;
  9. Cadet-Taïrou A, Gandilhon M, Toufik A, Evrard I. Phénomènes émergents liés aux drogues en 2006 [Emerging phenomena related to drugs in 2006]. Saint-Denis: OFDT; 2008;
  10. Casale JF, Klein RFX. Illicit production of cocaine. Forensic Science Review. 1993;(5):95–107
  11. Casale J, Corbeil E, Hays P. Identification of levamisole impurities found in illicit cocaine exhibits. Microgram Journal. 2008;6(3–4):82–89
  12. Casale JF, Boudreau DK, Jones LM. Tropane ethyl esters in illicit cocaine: Isolation, detection, and determination of new manufacturing by-products from the clandestine purification of crude cocaine base with ethanol. Journal of Forensic Sciences. 2008;53(3):661–667
  13. Caulkins JP. Price and purity analysis for illicit drug: Data and conceptual issues. Drug and Alcohol Dependence. 2007;90(Suppl. 1):S61–68
  14. Caulkins JP, Reuter P. Setting goals for drug policy: Harm reduction or use reduction?. Addiction. 1997;92(9):1143–1150
  15. Coomber R. Adulteration of drugs: The discovery of a myth. Contemporary Drug Problems. 1997;24(2):239–271
  16. Coomber R. The adulteration of drugs: What dealers do, what dealers think. Addiction Research. 1997;5(4):297–306
  17. Decorte T. Quality control by cocaine users: Underdeveloped harm reduction strategies. European Addiction Research. 2001;7(4):161–175
  18. Derlet RW, Albertson TE, Tharratt RS. Lidocaine potentiation of cocaine toxicity. Annals of Emergency Medicine. 1991;20(2):135–138
  19. DGS. (2008). Note d’information sur les risques sanitaires liés à la présence de phénacétine en tant que produit de coupe de la cocaïne [Information and warning about the risks due to phenacetin used as cutting agent in cocaine].
  20. EMCDDA . Purity of cocaine products at retail level 2006. Lisbon: EMCDDA; 2006;
  21. EMCDDA . Cocaine and crack cocaine: A growing public health issue. Lisbon: European monitoring center for drug and drug addiction; 2007;
  22. EMCDDA . The state of the drugs problem in Europe. In: Annual report 2008. Lisbon: EMCDDA; 2008;
  23. Fucci N. Unusual adulterants in cocaine seizured on Italian clandestine market. Forensic Science International. 2007;172(2–3):e1
  24. Fucci N, De Giovanni N. Adulterants encountered in the illicit cocaine market. Forensic Science International. 1998;95(3):247–252
  25. Goudie AJ, Sumnall HR, Field M, Clayton H, Cole JC. The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases. Drug and Alcohol Dependence. 2007;89(2–3):107–115
  26. Griffiths P, Vingoe L, Hunt N, Mounteney J, Hartnoll R. Drug information systems. Early warning, and new drug trends: Can drug monitoring systems become more sensitive to emerging trends in drug consumption?. Substance Use and Misuse. 2000;35(6–8):811–844
  27. Hoffman RS, Kirrane BM, Marcus SM. A descriptive study of an outbreak of clenbuterol-containing heroin. Annals of Emergency Medicine. 2008;52(5):548–553
  28. Johnson BD, Golub A. The potential for accurately measuring behavioral and economic dimensions of consumption, prices, and markets for illegal drugs. Drug and Alcohol Dependence. 2007;90(Suppl. 1):S16–26
  29. Kenyon SL, Ramsey J, Lee T, Johnston A, Holt D. Analysis for identification in amnesty bin samples from dance venues. Therapeutic Drug Monitoring. 2005;27(6):793–798
  30. King LA. Drug content of powder and other illicit preparations in the UK. Forensic Science International. 1997;(85):135–147
  31. Kinzie E. Levamisole found in patients using cocaine. Annals of Emerging Medicine. 2009;53(4):546–547
  32. Kort PM, Caulkins JP, Hartl RF, Feichtinger G. Brand image and brand dilution in the fashion industry. Automatica. 2006;42(8):1363–1370
  33. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174
  34. Legleye, S., Spilka, S., Le Nézet, O., & Laffiteau, C. (2009). Les drogues à 17 ans – Résultats de l’enquête ESCAPAD 2008 [Drug use of the 17 years old – Results of the 2008 ESCAPAD Survey]. Tendances(66).
  35. Lloyd-Smith E, Wood E, Li K, Montaner JS, Kerr T. Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors. Drug and Alcohol Dependence. 2009;99(1–3):176–182
  36. Lombard J, Levin J, Weiner W. Arsenic intoxication in a cocaine abuser. New England Journal of Medicine. 1989;(320):869–1869
  37. Morley S, Forrest A, Galloway J. Levamisole as a contaminant of illicit cocaine. Journal of Clandestine Laboratory Investigating Chemists Association. 2006;16(4):11
  38. Musset, T., Fathi, M., Magnin, A., & Mani, C. (2005). Analyses chimiques d’échantillons d’héroïne et de cocaïne consommés dans les rues de Genève [Chemical analyses of street heroine and cocaine in Genova]. Dépendances.
  39. Musto D. The American disease: Origins of narcotic control. New York: Oxford University; 1987;
  40. Nogue S, Sanz P, Munne P, de la Torre R. Acute scopolamine poisoning after sniffing adulterated cocaine. Drug and Alcohol Dependence. 1991;(27):115–116
  41. OFDT. (2007). Note d’information SINTES du 21 décembre 2007 sur la phénacétine [Information and warning about the risk due to phenacetin use as cutting agent in cocaine]. Retrieved May 2009.
  42. ONDCP . The price and purity of illicit drugs: 1981 through the second quarter of 2003. Washington, DC: Executive Office of the President; 2004;
  43. Quandt C, Sommi RJ, Pipkin T, McCallum M. Differentiation of cocaine toxicity: Role of the toxicology drug screen. Drug intelligence and clinical pharmacy. 1988;22(7–8):582–587
  44. Rowbotham MC, Hooker WD, Mendelson J, Jones RT. Cocaine–calcium channel antagonist interactions. Psychopharmacology (Berl). 1987;93(2):152–154
  45. SAMSHA. (2009). Nationwide public health alert issued concerning life-threatening risk posed by cocaine laced with veterinary anti-parasite drug. Substance abuse and mental health services administration Retrieved October 2009, from www.samsha.gov/newsroom/advisories/090921vet5101.aspx.
  46. Schindler CW, Srihari TR, Hashim EK, Steven GR. Pharmacological mechanisms in cocaine's cardiovascular effects. Drug and Alcohol Dependence. 1995;37(3):183–191
  47. Sefedov R. Early warning system. EMCDDA issues alert on cocaine/atropine intoxication. Drugnet Europe. 2005;50(April–June):6
  48. Shane D, Kaye S, Libby T. Cocaine use in New South Wales. Australia, 1996–2000: 5-year monitoring of trends in price, purity, availability and use from the illicit drug reporting system. Drug and Alcohol Dependence. 2002;67(1):81–88
  49. Simonsen KW, Kaa E, Rolmann DN. Narcotics at street level in Denmark a prospective investigation from 1995 to 2000. Forensic Science International. 2003;(131):162–170
  50. Vroegop M, Franssen E, van der Voort P, van der Berg T, Langeweg R, Kramers C. The emergency care of cocaine intoxications. The Netherlands Journal of Medicine. 2009;67(4):122–126
  51. Weiner AL, Bayer MJ, MacKay CAJ, Demeo M, Starr E. Anticholinergic poisoning with adulterated intranasal cocaine. The American Journal of Emergency Medicine. 1998;16(5):517–520
  52. Zhu N, Le Gatt D, Turner A. Agranulocytosis after consumption of cocaine adulterant with levamisole. Annals of Internal Medicine. 2009;150(4):287–289

PII: S0955-3959(10)00058-7

doi: 10.1016/j.drugpo.2010.03.004

International Journal of Drug Policy
Volume 21, Issue 5 , Pages 399-406 , September 2010

Article Tools